Found 5 matching trials
A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma PHASE2 sEphB-HSA may prevent tumor cells from multiplying and blocks several compo...
Show More Location
Sarcoma Oncology Center
Learn More & Join Trial
sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC PHASE1 This is a Phase I dose-escalation study of sEphB4-HSA in combination with c...
Show More Location
University of Colorado Hospital
Learn More & Join Trial
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors PHASE2 Patients with solid tumors that have high expression levels of EphrinB2 are...
Show More Location
Sarcoma Oncology Center
Learn More & Join Trial
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent PHASE2 This trial studies the side effects of recombinant EphB4-HSA fusion protein...
Show More Location
USC / Norris Comprehensive Cancer Center
Learn More & Join Trial
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors PHASE1 This pilot phase Ib trial studies the side effects and best dose of recombi...
Show More Status
Active Not Recruiting
Location
USC / Norris Comprehensive Cancer Center
Learn More & Join Trial